已为您找到该学者10条结果 成果回收站
杨洋, Yang Yang, Seisho Takeuchi, Wolf K. Hofmann, Takayuki Ikezoe, Jacques J.M. van Dongen, Tomasz Szczepa
Leukemia Research 30 (2006) 98–102,-0001,():
-1年11月30日
Methylation profile was analyzed in 10 childhood acute lymphoblastic leukemia (ALL) and nine adult ALL cases. Four genes (p15, p16, RARβ, FHIT) had methylation in both diseases, four genes (p14, Rb, MLH1, DAPK) showed no methylation in both diseases, and the two genes (APC, RIZ) demonstrated methylation only in adult ALL. Methylation of the RARβ was more frequent in adult ALL than that in childhood ALL (p = 0.01). The number of patients with methylation of multiple genes was higher in adult ALL than that in childhood ALL (p = 0.006). Moreover, overall frequency of methylation was higher in adult ALL than that in childhood ALL (p = 0.01).
Methylation, Multiple genes, ALL
-
51浏览
-
0点赞
-
0收藏
-
0分享
-
187下载
-
0
-
引用
杨洋, Yang Yang, Takeyuki Ikezoe, , Tsuyako Saito, Makoto Kobayashi, H. Phillip Koeffler and Hirokuni Taguchi
Cancer Sci February 2004 vol. 95 no. 2 ,-0001,():
-1年11月30日
Proteasome inhibitor PS-341 induces growth arrest and apoptosis of multiple myeloma (MM) cells via inactivation of NF-κB in vitro and has afforded some objective responses in individuals with relapsed, refractory MM. However, the activity of PS-341 against non-hematological malignancies remains to be fully elucidated. In this study, we found that PS-341 induced growth arrest and apoptosis of NCI-H520 and -H460 non-small cell lung cancer (NSCLC) cells in conjunction with markedly up-regulated levels of p21waf1 and p53, and down-regulation of bcl-2 protein in these cells. Also, PS-341 caused phosphorylation of c-Jun NH2-terminal kinase (JNK) and c-Jun, and enhanced AP-1/DNA binding activities in these cells as measured by western blotting and enzyme-linked immunosorbent assay (ELISA), respectively. Interestingly, when the JNK/ c-Jun/AP-1 signal pathway was disrupted by the JNK inhibitor SP600125, the ability of PS-341 to inhibit the growth of NSCLC cells and to up-regulate the levels of p21waf1 in these cells was blunted, but the expression of p53 was sustained at a high level, suggesting that the JNK/c-Jun/AP-1 signal pathway might mediate the anti-lung cancer effects of PS-341, with p21waf1 playing the central role. Thus, PS-341 might be useful for the treatment of individuals with NSCLC. (Cancer Sci 2004; 95: 176–180)
-
24浏览
-
0点赞
-
0收藏
-
0分享
-
139下载
-
0
-
引用
杨洋, Yang Yang, , Takayuki Ikezoe, Chie Nishioka, Takahiro Taguchi, Wei-guo Zhu, H. Phillip Koeffler and Hirokuni Taguchi
Cancer Sci December 2006 vol. 97 no. 12 1407,-0001,():
-1年11月30日
ZD6474 (Zactima, AstraZeneca, Macclesfield, UK) is an orally available, small-molecule inhibitor of vascular endothelial growth factor receptor-2 and epidermal growth factor receptor tyrosine kinases, with additional activity versus rearranged during transfection (RET). This study explored the effect of ZD6474 in gastrointestinal stromal tumor-T1 (GIST-T1) cells that possess a gain of function mutation in exon 11 of the c-KIT gene. ZD6474 induced growth arrest and apoptosis of GIST-T1 cells in association with blockade of c-Kit and its downstream effectors, including Akt and extracellular signal-regulated kinase (ERK). ZD6474 treatment also blocked the mammalian target of rapamycin (mTOR), which lies downstream of Akt and ERK. Interestingly, when ZD6474 was combined with sunitinib (SU11248; Sutent, Pfizer, Kalamazoo, MI, USA), a class III and V receptor tyrosine kinase inhibitor, the ZD6474-mediated growth inhibition was potentiated in association with further down-regulation of the mTOR targets p-p70S6K and p-4E-BP-1. The combination of ZD6474 and sunitinib should be investigated further. (Cancer Sci 2006; 97: 1404–1409)
-
53浏览
-
0点赞
-
0收藏
-
0分享
-
194下载
-
0
-
引用
杨洋, YANG YANG, TAKAYUKI IKEZOE, ZHIXING ZHENG, HIROKUNI TAGUCHI, H. PHILLIP KOEFFLER and WEI-GUO ZHU
INTERNATIONAL JOURNAL OF ONCOLOGY 31: 593-600, 2007,-0001,():
-1年11月30日
PC-SPES is an eight-herb mixture that has an activity against prostate cancer. Recently, we purified Saw Palmetto (Serenoa repens) from PC-SPES and found that Saw Palmetto induced growth arrest of prostate cancer LNCaP, DU145, and PC3 cells with ED50s of approximately 2.0, 2.6, and 3.3 μl/ml, respectively, as measured by mitochondrialdependent conversion of the the 3-(4, 5-dimethylthiazol-2-yl)- 2, 5-diphenyltetrazolium bromide (MTT) assay. Saw Palmetto induced apoptosis of LNCaP cells in a time- and dosedependent manner as measured by TUNEL assays. Also, Saw Palmetto increased the expression of p21waf1 and p53 protein in LNCaP cells. In addition, we found that Saw Palmetto down-regulated DHT- or IL-6-induced expression of prostate specific antigen in conjunction with down-regulation of the level of androgen receptor in the nucleus as measured by Western blot analysis. Moreover, Saw Palmetto downregulated the IL-6-induced level of the phosphorylated form of STAT 3 in LNCaP cells. Furthermore, Saw Palmetto inhibited the growth of LNCaP cells present as tumor xenografts in BALB/c nude mice without adverse effect. These results indicate that Saw Palmetto might be useful for the treatment of individuals with prostate cancer.
Saw Palometto, PSA,, prostate cancer, androgen receptor, STAT 3
-
70浏览
-
0点赞
-
0收藏
-
0分享
-
216下载
-
0
-
引用
杨洋, Yang Yang, Takayuki Ikezoe, , Tamotsu Takeuchi, Yoshihiro Adachi, Yuji Ohtsuki, Seisho Takeuchi, H. Phillip Koeffler and Hirokuni Taguchi
Cancer Sci July 2005 vol. 96 no. 7 425–433,-0001,():
-1年11月30日
This study found that the HIV-1 protease inhibitor nelfinavir (NFV) induced growth arrest and apoptosis of human prostate cancer cells (LNCaP, DU145 and PC-3 cells), as measured by MTT and terminal deoxyribonucleotide transferase-mediated dUTP nick end labeling (TUNEL) assays, respectively, on the third day of culture. In addition, NFV blocked androgen receptor (AR) signaling in association with downregulation of nuclear levels of AR in LNCaP cells as measured by reporter assay and western blot analysis. As expected, NFV downregulated the level of the AR target molecule prostate specific antigen in these cells. Moreover, NFV disrupted STAT3 signaling; protease inhibitors blocked interleukin-6-induced phosphorylation of STAT3 and inhibited STAT3 DNA binding activity in LNCaP and DU145 cells, as measured by western blot analysis and enzymelinked immunosorbent assay (ELISA), respectively. Furthermore, NFV blocked AKT signaling in prostate cancer cells as measured by kinase assay with glycogen synthase kinase-3α/β as a substrate. Importantly, NFV inhibited the proliferation of LNCaP cells presented as tumor xenografts in BALB/c nude mice without side-effects. Taken together, NFV inhibited the proliferation of prostate cancer cells in conjunction with blockade of signaling by AR, STAT3, and AKT, suggesting that this family of compounds might be useful for the treatment of individuals with prostate cancer. (Cancer Sci 2005; 96: 425–433)
-
39浏览
-
0点赞
-
0收藏
-
0分享
-
131下载
-
0
-
引用